Cases of diabetes and high cholesterol levels in Kelantan have seen an increase exceeding the national average indicators, says Health Minister Datuk Seri Dr Dzulkefly Ahmad. He said based on the ...

In a joint initiative by the Tun Hussein Onn National Eye Hospital and Malaysia’s Ministry of Health, the country’s first Cataract Carnival ...

A landmark resolution on lung health by Malaysia has been officially adopted by the World Health Organisation (WHO) in conjunction ...

Mental illness, cardiovascular disease, tobacco use, and injuries are now among the leading causes of death and disability in Southeast Asia, according to newly released research from the Institute ...

Achieving zero preventable dengue deaths is no longer an idealistic goal but a realistic one. By taking four simple actions — eliminating ...

A new report from global consultancy Kearney and the World Economic Forum’s Global Alliance for Women’s Health—supported by the Gates ...

Agilent Technologies and Ubix Therapeutics have signed a Memorandum of Understanding (MOU) to accelerate research and development of targeted cancer therapies in South Korea over the next five years.

Agilent Technologies and Ubix Therapeutics have signed a Memorandum of Understanding (MOU) to accelerate research and development of targeted cancer therapies in South Korea over the next five years.

Agilent Technologies and Ubix Therapeutics have signed a Memorandum of Understanding (MOU) to accelerate research and development of targeted cancer therapies in South Korea over the next five years.

Indonesia and Thailand have recently signed a memorandum of understanding on health cooperation as Covid-19 cases climb in Bangkok. President Prabowo Subianto formalized the agreement during an ...

The Covid-19 situation in Selangor is under control despite a spike of cases in neighbouring countries Thailand and Singapore, said state executive councillor for public health and environment ...

Cambodia’s Ministry of Health is calling for increased public vigilance as the COVID-19 subvariant JN.1 spreads rapidly worldwide. First detected in August 2023, JN.1 now accounts for over 15% of ...